TrialThe lancet. Diabetes & endocrinology2018

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial.

Richard E Pratley et al.PubMed ↗Publisher ↗

No numbers read from the abstract.